Form 4: PLAYSTUDIOS General Counsel Sells Over 40,000 Shares Under Pre-Arranged Trading Plan

Joel Agena, General Counsel of PLAYSTUDIOS, Inc., reported the sale of 40,980 shares of Class A Common Stock in late June 2025, executed under a Rule 10b5-1 trading plan.

Summary

• Joel Agena, General Counsel of PLAYSTUDIOS, Inc. (MYPS), reported the sale of 40,980 shares of the company's Class A Common Stock.
• On June 27, 2025, 20,490 shares were sold at a weighted average price of $1.34 per share, with prices ranging from $1.30 to $1.36.
• On June 30, 2025, an additional 20,490 shares were sold at a weighted average price of $1.32 per share, with prices ranging from $1.30 to $1.36.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Agena on March 12, 2025, and previously disclosed in the company's Quarterly Report on Form 10-Q filed on May 9, 2025.
• Following these sales, Mr. Agena directly beneficially owns 115,791 shares of Class A Common Stock.
• Mr. Agena also holds significant derivative securities, including 291,668 Restricted Stock Units, 125,000 Performance Stock Units, 233,043 Stock Options, and 28,040 Earnout Shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider sales can sometimes be viewed negatively, the fact that these transactions were conducted under a pre-arranged Rule 10b5-1 trading plan mitigates concerns about management confidence, indicating a planned financial management activity rather than a reaction to adverse company news.

Positives

• The stock sales were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and pre-disclosed approach to insider transactions rather than an immediate reaction to new information.
• The General Counsel retains a substantial holding of 115,791 Class A Common Stock shares and significant derivative securities, including 291,668 Restricted Stock Units, 125,000 Performance Stock Units, 233,043 Stock Options, and 28,040 Earnout Shares, aligning his interests with long-term shareholder value.

Negatives

• The sale of 40,980 shares by a key executive, the General Counsel, could be perceived negatively by some investors as it reduces insider ownership.
• The sale prices of $1.34 and $1.32 are relatively low, which might be interpreted by some as a lack of confidence in significant near-term price appreciation, although this is speculative given the 10b5-1 plan.

Risks

• Insider sales, even under a 10b5-1 plan, can sometimes be misinterpreted by the market as a signal of reduced confidence by management, potentially leading to negative investor sentiment.
• The future vesting of a large number of Restricted Stock Units and Performance Stock Units could lead to further sales by the reporting person, potentially increasing selling pressure on the stock.
• The achievement of earnout shares is contingent on the stock price reaching significantly higher thresholds ($12.50 and $15.00), which may not be met, meaning these shares may not vest.

Future Outlook

The document indicates future vesting schedules for a substantial number of Restricted Stock Units through January 2028 and Performance Stock Units contingent on 2025 fiscal year performance metrics. Additionally, 28,040 earnout shares are contingent on the Class A Common Stock reaching price targets of $12.50 and $15.00 by June 21, 2026.

Management Comments

• This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025. This trading plan was previously disclosed in the Issuer's Quarterly Report on Form 10-Q filed on May 9, 2025.

Industry Context

Insider transactions, such as those reported in a Form 4, are common in publicly traded companies. While sales by executives can sometimes raise questions about management's confidence, the disclosure that these sales were conducted under a Rule 10b5-1 plan is a standard practice designed to allow insiders to sell shares without being accused of trading on material non-public information. This practice is widely accepted across industries as a mechanism for executives to manage their personal finances while adhering to insider trading regulations.

Comparison to Industry Standards

• Direct comparisons to specific companies or projects are not applicable as this document details an individual insider transaction rather than company-wide financial performance or project results.
• The use of a Rule 10b5-1 trading plan for insider sales is a standard corporate governance practice in the U.S. and aligns with best practices for managing insider trading compliance. Many executives at companies like Apple, Microsoft, and Google utilize similar plans for their stock sales.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of shares by a General Counsel, even if pre-planned, could lead to minor concerns about insider confidence, but the Rule 10b5-1 plan helps to alleviate this. The remaining significant equity and derivative holdings indicate continued alignment with shareholder interests.

Next Steps

• Continued vesting of Restricted Stock Units on various dates through January 2028.
• Determination of Performance Stock Units vesting based on achievement of pre-established performance metrics for the fiscal year ending December 31, 2025.
• Potential vesting of Earnout Shares if Class A Common Stock price targets of $12.50 and $15.00 are met by June 21, 2026.

Key Dates

Keywords

PLAYSTUDIOS, MYPS, Form 4, insider trading, stock sale, Joel Agena, General Counsel, Rule 10b5-1, equity, restricted stock units, performance stock units, stock options, earnout shares